SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear CHDN Q1 2026 Earnings EPS Surges Past Estimates by 182 FUL Q1 2026 Earnings EPS Beats Estimates as Stock Rises 25 SLN Q4 2024 Earnings Positive EPS Amid Continued Clinical Progress AFLAC Q1 2026 Earnings EPS Miss Estimates Amid Stable Operations